Victhom announces results of the Annual General Meeting of shareholders
11 Junio 2012 - 3:38AM
PR Newswire (Canada)
QUEBEC, June 14, 2012 /CNW Telbec/ - Victhom Human Bionics Inc.
("Victhom") today reported the results of its Annual General
Meeting of shareholders held in Montreal, Quebec on June 13, 2012.
The shareholders approved the motions put forth at the meeting to
re-appoint the four directors of the Company: Daniel Johnson, Nitin
Kaushal, Martin Leblanc and Normand Rivard and to appoint Ernst
& Young LLP as the Company's auditors. At their meeting held
directly following the Annual General Meeting, the directors
re-appointed Mr. Daniel Johnson as Chairman of the Board. About
Victhom Victhom is a company which owns patents in the field of
orthotics and prosthetics (O&P), including intellectual
property used in the Power Knee, the world's first and only
motor-powered prosthesis for above-knee amputees, a product
distributed under license agreement by Ossur, a global leader in
the O&P market. The Company also has a royalty agreement
related to the Neurostep® System and neuromodulation products in
other indications (sleep apnea and epilepsy) using the Neurobionix
technology platform currently under development by Neurostream
Technologies, a General Partnership now owned by Otto Bock, a
global leader in the O&P market. FORWARD-LOOKING STATEMENTS
Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future
financial performance and involve known and unknown risks,
uncertainties and other factors that may cause Victhom's actual
results, performance or achievements to be materially different
from those expressed or implied by any of Victhom's statements.
Actual events or results may differ materially. We disclaim any
intention, and assume no obligation, to update these
forward-looking statements. VICTHOM HUMAN BIONICS INC. CONTACT:
Source: Victhom Human Bionics Inc.For more information: Normand
RivardPresident & CEOVicthom Human Bionics Inc.Tel.:
438-380-5244normand.rivard@victhom.comwww.victhom.com
Copyright
Victhom Human Bionics Inc. (TSXV:VHB)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Victhom Human Bionics Inc. (TSXV:VHB)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024
Real-Time news about Victhom Human Bionics Inc. (TSX Venture Exchange): 0 recent articles
Más de Victhom Human Bionics Inc. Artículos de Noticias